Literature DB >> 409398

Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3".

S M Strain, R Toubiana, E Ribi, R Parker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409398     DOI: 10.1016/s0006-291x(77)80001-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Three types of mycolic acid from Mycobacterium tuberculosis Brévanne: implications for structure-function relationships in pathogenesis.

Authors:  R Toubiana; J Berlan; H Sato; M Strain
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

3.  Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide.

Authors:  K N Masihi; W Brehmer; W Lange; H Werner; E Ribi
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.

Authors:  K Kaneda; Y Sumi; F Kurano; Y Kato; I Yano
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

6.  Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials.

Authors:  E Ribi; D L Granger; K C Milner; K Yamamoto; S M Strain; R Parker; R W Smith; W Brehmer; I Azuma
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

7.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.